ALC
Alcon AG
NYSE: ALC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$72.81
-3.44% today
Updated 2026-04-29
Market cap
$36.39B
P/E ratio
36.77
P/S ratio
3.50x
EPS (TTM)
$1.98
Dividend yield
0.48%
52W range
$72 – $99
Volume
1.5M
Alcon AG (ALC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2002 | 2005 | 2006 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $701.40M | $1.24B | $1.41B | $1.32B | $1.25B | $1.22B | $1.14B | $920.00M | $823.00M | $1.34B | $1.22B | $1.39B | $2.08B | $2.27B |
| Capital expenditures | $120.90M | $162.20M | $222.30M | $485.77M | $506.00M | $496.00M | $712.00M | $676.00M | $567.00M | $1.18B | $745.00M | $851.00M | $670.00M | $543.00M |
| Depreciation | $166.50M | $210.60M | $357.30M | $1.26B | $1.29B | $1.30B | $1.62B | $1.43B | $1.62B | $1.22B | $1.12B | $1.22B | $1.23B | — |
| Stock-based comp | $22.10M | $2.60M | $254.10M | $65.00M | $53.00M | $71.00M | $93.00M | $83.00M | $105.00M | $138.00M | $140.00M | $144.00M | $150.00M | $162.00M |
| Free cash flow | $580.50M | $1.07B | $1.18B | $832.06M | $739.00M | $722.00M | $428.00M | $244.00M | $256.00M | $165.00M | $472.00M | $537.00M | $1.41B | $1.73B |
| Investing cash flow | — | — | — | $-517.51M | $-843.00M | $-679.00M | $-1.00B | $-1.01B | $-572.00M | $-1.20B | $-1.86B | $-1.09B | $-1.17B | — |
| Financing cash flow | $-752.70M | $-433.00M | $-1.22B | $-796.47M | $-435.00M | $-539.00M | $-78.00M | $659.00M | $466.00M | $-123.00M | $-8.00M | $-211.00M | $-322.00M | — |
| Dividends paid | $1.24B | $302.00M | $416.80M | — | — | — | $54.00M | $54.00M | $54.00M | $54.00M | $100.00M | $116.00M | $130.00M | $166.00M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |